Neuromuscular blocking agents in the intensive care unit
Neuromuscular blocking agents (NMBA) are a controversial therapeutic option in the approach to the critically ill patient. They are not innocuous, and the available evidence does not support their routine use in the intensive care unit. If necessary, monitoring protocols should be established to avo...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-09-01
|
Series: | Journal of International Medical Research |
Online Access: | https://doi.org/10.1177/03000605221128148 |
_version_ | 1818030292263239680 |
---|---|
author | Jonathan Rodríguez-Blanco Tomás Rodríguez-Yanez Jesús Daniel Rodríguez-Blanco Amilkar José Almanza-Hurtado María Cristina Martínez-Ávila Diana Borré-Naranjo María Camila Acuña Caballero Carmelo Dueñas-Castell |
author_facet | Jonathan Rodríguez-Blanco Tomás Rodríguez-Yanez Jesús Daniel Rodríguez-Blanco Amilkar José Almanza-Hurtado María Cristina Martínez-Ávila Diana Borré-Naranjo María Camila Acuña Caballero Carmelo Dueñas-Castell |
author_sort | Jonathan Rodríguez-Blanco |
collection | DOAJ |
description | Neuromuscular blocking agents (NMBA) are a controversial therapeutic option in the approach to the critically ill patient. They are not innocuous, and the available evidence does not support their routine use in the intensive care unit. If necessary, monitoring protocols should be established to avoid residual relaxation, adverse effects, and associated complications. This narrative review discusses the current indications for the use of NMBA and the different tools for monitoring blockade in the intensive care unit. However, expanding the use of NMBA in critical settings merits the development of prospective studies. |
first_indexed | 2024-12-10T05:33:16Z |
format | Article |
id | doaj.art-e8ee8ec539dc4241a67bd45d0d1fbd79 |
institution | Directory Open Access Journal |
issn | 1473-2300 |
language | English |
last_indexed | 2024-12-10T05:33:16Z |
publishDate | 2022-09-01 |
publisher | SAGE Publishing |
record_format | Article |
series | Journal of International Medical Research |
spelling | doaj.art-e8ee8ec539dc4241a67bd45d0d1fbd792022-12-22T02:00:29ZengSAGE PublishingJournal of International Medical Research1473-23002022-09-015010.1177/03000605221128148Neuromuscular blocking agents in the intensive care unitJonathan Rodríguez-BlancoTomás Rodríguez-YanezJesús Daniel Rodríguez-BlancoAmilkar José Almanza-HurtadoMaría Cristina Martínez-ÁvilaDiana Borré-NaranjoMaría Camila Acuña CaballeroCarmelo Dueñas-CastellNeuromuscular blocking agents (NMBA) are a controversial therapeutic option in the approach to the critically ill patient. They are not innocuous, and the available evidence does not support their routine use in the intensive care unit. If necessary, monitoring protocols should be established to avoid residual relaxation, adverse effects, and associated complications. This narrative review discusses the current indications for the use of NMBA and the different tools for monitoring blockade in the intensive care unit. However, expanding the use of NMBA in critical settings merits the development of prospective studies.https://doi.org/10.1177/03000605221128148 |
spellingShingle | Jonathan Rodríguez-Blanco Tomás Rodríguez-Yanez Jesús Daniel Rodríguez-Blanco Amilkar José Almanza-Hurtado María Cristina Martínez-Ávila Diana Borré-Naranjo María Camila Acuña Caballero Carmelo Dueñas-Castell Neuromuscular blocking agents in the intensive care unit Journal of International Medical Research |
title | Neuromuscular blocking agents in the intensive care unit |
title_full | Neuromuscular blocking agents in the intensive care unit |
title_fullStr | Neuromuscular blocking agents in the intensive care unit |
title_full_unstemmed | Neuromuscular blocking agents in the intensive care unit |
title_short | Neuromuscular blocking agents in the intensive care unit |
title_sort | neuromuscular blocking agents in the intensive care unit |
url | https://doi.org/10.1177/03000605221128148 |
work_keys_str_mv | AT jonathanrodriguezblanco neuromuscularblockingagentsintheintensivecareunit AT tomasrodriguezyanez neuromuscularblockingagentsintheintensivecareunit AT jesusdanielrodriguezblanco neuromuscularblockingagentsintheintensivecareunit AT amilkarjosealmanzahurtado neuromuscularblockingagentsintheintensivecareunit AT mariacristinamartinezavila neuromuscularblockingagentsintheintensivecareunit AT dianaborrenaranjo neuromuscularblockingagentsintheintensivecareunit AT mariacamilaacunacaballero neuromuscularblockingagentsintheintensivecareunit AT carmeloduenascastell neuromuscularblockingagentsintheintensivecareunit |